SLC34A2 and prostate carcinoma: RP3-416H24.1 was connected with seven mRNAs (SPINT1, PROM1, MMP7, VTCN1, AQP1, KRT19, SLC34A2, and ITGB4) and enriched in prostate cancer, transcriptional disorders in cancer, the Wnt signaling pathway, human T-cell leukemia virus 1 infection, ECM–receptor interaction, hypertrophic cardiomyopathy, staphylococcus aureus infection, bile secretion, metabolic pathways, fatty acid metabolism, and other signaling pathways.